News
Pfizer CEO thinks pharma tariffs won’t be applied equally
For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an interview that there’s room for other products as more doctors become aware of the disease and patients get diagnosed earlier. Read more.
The Trump administration said in mid-April to expect tariffs on drug imports in a month or so, which puts the deadline ...
Goldman Sachs keeps Neutral on Pfizer, citing unclear product growth plans and focus on M&A amid changing market valuations ...
Nevertheless, Albert Bourla has been lobbying the U.S. government—as high as President Donald Trump himself—to skip the ...
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...
Miky Lee, producer behind Oscar-winning 'Parasite', is set to be honored with the Ellis Island Medal of Honor. She joins ...
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist ...
1don MSN
Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback